Preclinical drug development
Outsourced early development – Planning and managing a preclinical development with partner PKI
smv3 news
Outsourced early development – Planning and managing a preclinical development with partner PKI
We congratulate MALDI bioapplications specialist mabritec AG to its upcoming 10th anniversary and its new website
University of Oxford spinoff “OMass Technologies” visits Switzerland on march 16, 2018 – interested in meeting them?
Read about our work for Art exhibition “TonArt-TonWerk-DieZweite” in Lausen
The University of Basel hires smv3.ch for an analytical lecture in the ‘Master of Drug Sciences’ course